Chief Financial Officer · Sionna Therapeutics, Inc. (SION)

Elena Ridloff

A named executive officer of Sionna Therapeutics in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,857,367

FY2024: $1,300,647

Compensation figures as of the proxy filed April 27, 2026 (DEF 14A).

Elena Ridloff compensation by year

Sionna Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Sionna Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$449,946$506,677
Bonus$0$0
Stock awards$0$0
Option awards$652,725$2,085,765
Non-equity incentive$197,976$254,925
Pension and deferred compensation$0$0
All other$0$10,000
Total$1,300,647$2,857,367

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sionna Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001628280-26-027489, and prior-year filings. Open the filing on EDGAR.

$1.3M
$2.9M
FY24
FY25
SalaryNon-equity incentiveOption awardsAll other

Sionna Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Michael CloonanPresident and Chief Executive Officer$6,981,217
Caroline Stark BeerChief Business Officer$5,592,896
Elena Ridloff · this pageChief Financial Officer$2,857,367

The full Sionna Therapeutics compensation record

free company brief

This page is one person within Sionna Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Sionna Therapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sionna Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy